Abstract:ABSTRACT Reverse genetics systems for rotaviruses (RV) facilitate the generation of genetically engineered RVs by transfection of 11 plasmids encoding 11 genomic viral RNA segments. In addition to viral genome expression, overexpression of NSP2 and NSP5 has been used to increase the rescue efficiency of recombinant RVs. Here, we showed that the overexpression of nucleotide sequence-modified NSP2 and NSP5 enabled the rapid and efficient production of recombinant RVs. Using improved reverse genetics, we established a reverse genetics system for human and bovine RV clinical isolates, as well as laboratory strains of bovine RV (NCDV and UK) and porcine RV (Gottfried). In addition, we rescued low-replicating recombinant RVs carrying a mutant NSP4 lacking the double-layered particle-binding domain, which was deficient in the efficient production of mature virions. These advancements in reverse genetics enabled the generation of molecular clones of RV clinical isolates and recombinant RVs harboring critical amino acid mutations, offering a versatile platform for investigating RV biology and pathogenesis. IMPORTANCE Recombinant rotavirus (RV) synthesis via reverse genetics relies on both the viral propagation capacity and the efficiency of the experimental system. Since the establishment of our reverse genetics system, several enhancements have been implemented to augment the rescue efficiency. Nevertheless, challenges persist in generating RV clinical strains and recombinant viruses with low replication capacities. Notably, this improved reverse genetics system successfully facilitated the establishment of molecular clones of human and bovine RV clinical isolates. Fecal samples from patients with RV typically harbor quasi-species or, occasionally, multiple genotypes of RV. In the present study, we performed the genetic sequencing of clinical viral strains during the early propagation stages in cultured cells. Subsequently, infectious viruses were synthesized, allowing the characterization of circulating viruses in nature. This approach provides valuable insights into the genetic diversity and dynamics of RV populations and contributes to a more comprehensive understanding of viral pathogenesis and evolution.

Rescue of recombinant Newcastle disease virus: a short history of how it all started

The Reverse Genetics Systems for Human and Animal RNA Viruses

Rescue of recombinant Newcastle disease virus: current cloning strategies and RNA polymerase provision systems

Rescue of recombinant Newcastle disease virus: a promising vector with two decades of intensive vaccine research

Rescue of Recombinant Newcastle Disease Virus by Reverse Genetic System

Rescue of an Enterotropic Newcastle Disease Virus Strain ZM10 from Cloned Cdna and Stable Expressing an Inserted Foreign Gene

Comparison of the Efficiency of Different Newcastle Disease Virus Reverse Genetics Systems

Rescue of a recombinant Newcastle disease virus strain R2B expressing green fluorescent protein

Two-plasmid system to increase the rescue efficiency of paramyxoviruses by reverse genetics: The example of rescuing Newcastle Disease Virus

Rapid Generation of a Recombinant Genotype VIII Newcastle Disease Virus (NDV) Using Full-Length Synthetic cDNA

Recombinant Newcastle Disease Virus-Vectored Vaccines Against Human and Animal Infectious Diseases

Rescue of a Plant Negative-Strand RNA Virus from Cloned Cdna: Insights into Enveloped Plant Virus Movement and Morphogenesis.

The Advancement on Recombinant Newcastle Disease Virus As a Vaccine Vector

Application of the Ligation-Independent Cloning (LIC) Method for Rapid Construction of a Minigenome Rescue System for Newcastle Disease Virus VG/GA Strain

Rescuing Newcastle disease virus with tag for screening viral-host interacting proteins based on highly efficient reverse genetics

rescue of arboviruses directly from subgenomic DNA fragments

Rescue of Recombinant Peste Des Petits Ruminants Virus: Creation of a GFP-expressing Virus and Application in Rapid Virus Neutralization Test

Dual Promoters Improve the Rescue of Recombinant Measles Virus in Human Cells

Progress on the Newcastle Disease Virus Vector

Rapid production of recombinant rotaviruses by overexpression of NSP2 and NSP5 genes with modified nucleotide sequences

Rescue of a recombinant Newcastle disease virus expressing the green fluorescent protein]